Number of Nations Logging onto Rose 29% in 2013

SOMERSET, N.J., Jan. 6, 2014 – The number of nations that logged onto the Post-Finasteride Syndrome Foundation website rose 29 percent in 2013, according to Google Analytics.

In all, users in 120 countries outside the United States—or 61 percent of the world (as defined by the 195 nations recognized by the U.S. Department of State)—accessed information on the condition via, versus 85 foreign countries in 2012.

Visits from abroad now comprise 59 percent of the site’s total annual traffic.

Patient inquiries directly to the foundation, via email and/or phone, reveal a similar breakdown: Since the launch of in 2012, 58 percent of all such queries have come from outside the U.S.

PFS has been reported to occur in men who have taken the prescription drug finasteride to treat hair loss (under the brand name Propecia and generics), or enlarged prostates (Proscar and generics).

Reported symptoms include loss of libido, erectile dysfunction, suicidal ideation, anxiety, panic attacks, Peyronie’s disease, penile shrinkage, gynecomastia, muscle atrophy, cognitive impairment, severely dry skin, tinnitus, and depression. The condition often has a life-altering impact on victims and their families, such as job loss and the breakup of marriages and romantic relationships, while also being linked to suicides.

“Though website traffic is just one of many factors in understanding the scope of PFS, last year’s growth in the number of nations downloading information from appears to indicate steadily increasing awareness of this often-devastating condition in every corner of the globe,” said PFS Foundation CEO Dr. John Santmann.

Following are additional Google Analytics surrounding use in 2013:

Site popularity by nation (top 50 of 121)

1: USA
2: Germany
3: United Kingdom
4: Canada
5: Japan
6: Australia
7: Italy
8: Brazil
9: Spain
10: Netherlands
11: Switzerland
12: India
13: Poland
14: Ireland
15: Austria
16: South Korea
17: Belgium
18: France
19: Norway
20: Greece
21: Turkey
22: Portugal
23: Argenita
24: Finland
25: Israel
26: New Zealand
27: Singapore
28: South Africa
29: Denmark
30: Mexico
31: Thailand
32: Hungary
33: Russia
34: Saudi Arabia
35: China
36: Malaysia
37: Philippines
38: Trinidad and Tobago
39: Serbia
40: United Arab Emirates
41: Iran
42: Venzuela
43: Hong Kong
44: Columbia
45: Ukraine
46: Pakistan
47: Cyprus
48: Indonesia
49: Luxembourg
50: Slovenia

Site popularity by language (top 10)

1: English
2: German
3: Japanese
4: Portuguese
5: Italian
6: Spanish
7: Polish
8: Dutch
9: French
10: Korean

Top 10 most popular landing pages

1: Home page

2: PFS Syndrome Overview

3: News release: Clinical Study of Post-Finasteride Syndrome Launched at Brigham and Women’s Hospital

4: Medical Awareness: Doctors Begin Recruiting PFS Patients for Research Studies

5: Donate

6: PFS Clinical Research Initiatives

7: Published PFS Clinical Research

8: News release: Clinical Study of Post-Finasteride Syndrome Launched at Baylor College of Medicine

9: News release: Post-Finasteride Syndrome Foundation Sponsors PFS Roundtable for Medical Researchers at International Meeting on Steroids and the Nervous System

10: Post Finasteride Syndrome Foundation News

2013 intra-year growth (unique visits)

  • Traffic up 22% during July 1-Dec. 31 over Jan. 1-June 30.

Users by age group

  • 25-34          33.5%
  • 18-24          27.5%
  • 35-44          15.5%
  • 45-54          12.5%
  • 55-64          5.50%
  • 65+              5.50%

Users by gender

  • Male: 54.15%
  • Female: 45.85%

About the PFS Foundation

Headquartered in Somerset N.J., the Post-Finasteride Syndrome Foundation was established in July 2012 as a 501(c)(3) organization, with private grants from families in the U.S. and abroad.  Tax-deductible financial donations to the nonprofit organization can be made via, which also houses patient-recruitment information on active clinical studies, published research, research goals, and media reports about PFS.

#     #     #


Media Relations Manager
The Post-Finasteride Syndrome Foundation